These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 3936056)

  • 1. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
    Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
    Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
    Marten W; Weiss M; Haase W
    Curr Med Res Opin; 1984; 9(2):96-106. PubMed ID: 6443349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
    Uusitalo A
    Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
    Akhras F; Chambers J; Jefferies S; Jackson G
    Int J Cardiol; 1989 Aug; 24(2):191-6. PubMed ID: 2504673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris.
    Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Reinikainen P
    Eur Heart J; 1988 Dec; 9(12):1339-47. PubMed ID: 3147892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of dermal glyceryl trinitrate and isosorbide dinitrate for patients with angina pectoris.
    Hubner PJ; Jones PR; Galer IA
    Br Med J (Clin Res Ed); 1985 Feb; 290(6467):514-6. PubMed ID: 3918653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
    Walker JM; Curry PV; Bailey AE; Steare SE
    Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
    Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
    Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of long term treatment and different dosage regimens of isosorbide 5-mononitrate.
    Meffert M; Paeckelmann IM
    Drugs; 1987; 33 Suppl 4():104-10. PubMed ID: 3622314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of nitrates.
    Bogaert MG
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):693-9. PubMed ID: 7873466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre open comparison of isosorbide-5-mononitrate and nifedipine given prophylactically to general practice patients with chronic stable angina pectoris.
    Ankier SI; Fay L; Warrington SJ; Woodings DF
    J Int Med Res; 1989; 17(2):172-8. PubMed ID: 2656333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20).
    van Hasselt M; Weiss M; Haase W
    Curr Med Res Opin; 1984; 9(2):107-12. PubMed ID: 6443348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of time and dosage of isosorbide mononitrate on objective and subjective parameters in angina pectoris].
    Herrmann H; Kuhl A; Maier-Lenz H
    Arzneimittelforschung; 1988 May; 38(5):694-8. PubMed ID: 3415710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
    Gunasekara NS; Noble S
    Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow-release isosorbide-5-mononitrate--a new once daily therapeutic modality for angina pectoris.
    Ahmadinejad M; Eghbal B; Sorgenicht W; Schneeweiss A; Weiss M
    Eur Heart J; 1988 Jan; 9 Suppl A():135-9. PubMed ID: 3137063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
    Hughes LO; DasGupta P; Jain D; Lahiri A; Raftery EB
    Eur J Clin Pharmacol; 1989; 36(2):139-44. PubMed ID: 2498105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
    Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
    Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind randomised crossover trial comparing isosorbide dinitrate cream and oral sustained-release tablets in patients with angina pectoris.
    Handler CE; Sullivan ID
    Int J Cardiol; 1985 Feb; 7(2):149-57. PubMed ID: 3882583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.